These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23488249)

  • 1. Suggestion in the treatment of depression.
    Kirsch I; Low CB
    Am J Clin Hypn; 2013 Jan; 55(3):221-9. PubMed ID: 23488249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The power of belief and expectancy in understanding and management of depression.
    Alladin A
    Am J Clin Hypn; 2013 Jan; 55(3):249-71. PubMed ID: 23488252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants.
    Freeman MP; Mischoulon D; Tedeschini E; Goodness T; Cohen LS; Fava M; Papakostas GI
    J Clin Psychiatry; 2010 Jun; 71(6):682-8. PubMed ID: 20573327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant medications, placebo, and the use of hypnosis in the treatment of depression.
    Frischholz EJ
    Am J Clin Hypn; 2013 Jan; 55(3):209-14. PubMed ID: 23488247
    [No Abstract]   [Full Text] [Related]  

  • 5. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatry should not become hostage to placebo: an alternative interpretation of antidepressant-placebo differences in the treatment response in depression.
    Rihmer Z; Dome P; Baldwin DS; Gonda X
    Eur Neuropsychopharmacol; 2012 Nov; 22(11):782-6. PubMed ID: 22497852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does a placebo run-in or a placebo treatment cell affect the efficacy of antidepressant medications?
    Trivedi MH; Rush H
    Neuropsychopharmacology; 1994 Aug; 11(1):33-43. PubMed ID: 7945742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.
    Sinyor M; Levitt AJ; Cheung AH; Schaffer A; Kiss A; Dowlati Y; Lanctôt KL
    J Clin Psychiatry; 2010 Mar; 71(3):270-9. PubMed ID: 20122371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is drug-placebo difference in short-term antidepressant drug trials on unipolar major depression much greater than previously believed?
    Rihmer Z; Gonda X
    J Affect Disord; 2008 Jun; 108(3):195-8. PubMed ID: 18280581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the presence of an open-label antidepressant treatment period influence study outcome in clinical trials examining augmentation/combination strategies in treatment partial responders/nonresponders with major depressive disorder?
    Iovieno N; Papakostas GI
    J Clin Psychiatry; 2012 May; 73(5):676-83. PubMed ID: 22569112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis.
    Iovieno N; Papakostas GI
    J Clin Psychiatry; 2012 Oct; 73(10):1300-6. PubMed ID: 23140647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can people with nonsevere major depression benefit from antidepressant medication?
    Stewart JA; Deliyannides DA; Hellerstein DJ; McGrath PJ; Stewart JW
    J Clin Psychiatry; 2012 Apr; 73(4):518-25. PubMed ID: 22226407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypnosis in treating symptoms and risk factors of major depression.
    Yapko M
    Am J Clin Hypn; 2001 Oct; 44(2):97-108. PubMed ID: 11591085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating depression with antidepressants: drug-placebo efficacy debates limit broader considerations.
    Yapko MD
    Am J Clin Hypn; 2013 Jan; 55(3):272-90. PubMed ID: 23488253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel approaches to drug-placebo difference calculation: evidence from short-term antidepressant drug-trials.
    Rihmer Z; Gonda X; Döme P; Erdős P; Ormos M; Pani L
    Hum Psychopharmacol; 2011; 26(4-5):307-12. PubMed ID: 21755539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression severity and effect of antidepressant medications.
    Elkin I
    JAMA; 2010 Apr; 303(16):1596; author reply 1599. PubMed ID: 20424243
    [No Abstract]   [Full Text] [Related]  

  • 17. Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials.
    Khan A; Brodhead AE; Kolts RL; Brown WA
    J Psychiatr Res; 2005 Mar; 39(2):145-50. PubMed ID: 15589562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methodological issues in clinical trials of antidepressant medications: perspectives from psychotherapy outcome research.
    Gaudiano BA; Herbert JD
    Psychother Psychosom; 2005; 74(1):17-25. PubMed ID: 15627852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression.
    Dimidjian S; Hollon SD; Dobson KS; Schmaling KB; Kohlenberg RJ; Addis ME; Gallop R; McGlinchey JB; Markley DK; Gollan JK; Atkins DC; Dunner DL; Jacobson NS
    J Consult Clin Psychol; 2006 Aug; 74(4):658-70. PubMed ID: 16881773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placebo-controlled, antidepressant clinical trials cannot be shortened to less than 4 weeks' duration: a pooled analysis of randomized clinical trials employing a diagnostic odds ratio-based approach.
    Tedeschini E; Fava M; Papakostas GI
    J Clin Psychiatry; 2011 Jan; 72(1):98-113. PubMed ID: 21208576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.